Filter posts

PhRMA & BIO release joint principles on communications with health care professionals and payers

We are in an era of data-driven medicine. Patients, caregivers, health care professionals and insurers …

Setting the Stage for PDUFA VI: Recap of Stakeholder Briefing

On July 15, 2016, the U.S. Food and Drug Administration (FDA) released the Prescription Drug …

New Report Shows Value of Quality Measures for Adult Vaccines

Every year, more than 40,000 American adults are hospitalized or die due to vaccine-preventable diseases. …

Take Action: Sarcoma Awareness Month

The pages on the calendar have quickly turned and July is again upon us.  For …

Conference on Clinical Research for Rare Diseases on November 3rd

BIO members may be interested in the upcoming Conference on Clinical Research for Rare Diseases, …

8 Reasons New Medicines are Needed for Alzheimer’s

Last week, the Alzheimer’s Association released an infographic with eight mythbusting facts to help dispel …

Bloomberg Caught Spreading Another Inaccurate “False Alarm” About Drug Prices

I was deeply disturbed by Bloomberg’s inaccurate report this morning that attempted to examine drug …

ICYMI: Gov. Tom Ridge, Tara O’Toole on Investing in Bioscience to Protect Against Bioterror

Writing in the Pittsburgh Post-Gazette last week, Governor Tom Ridge and Tara O’Toole remind us …

ICER’s Methodology Needs to Take Into Account Key Stakeholder Voices

Last week, the Institute for Clinical and Economic Review (ICER) released the scoping document for …

Stop Demeaning the Healthy Dialogue Between Doctors and Drug Companies

A recent report in The Wall Street Journal entitled, “Even Cheap Meals Influence Doctors’ Drug …